Comprehending the ways in which NF-κB influences inflammation, immunological response, and cell survival in the context of smoking-induced lung cancer is essential for the creation of focused therapeutic approaches (Bhat et al., 2023[19]; Qiu et al., 2017[156]). This evidence concerns the gene NFKB1 and lung carcinoma.